Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/2006
02/09/2006US20060029922 free of growth hormones in amounts hazardous for consumption; culturing in vitro non-human animal cells selected from the group consisting of muscle cells, somite cells and stem cells, in a medium free of hazardous substances for humans, thereby producing a three dimensional animal muscle tissue
02/09/2006US20060029639 Biodegradable substrate, prosthetic material for tissue regeneration, and cultured tissue
02/09/2006US20060029638 Methods for treating body tissue
02/09/2006US20060029619 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
02/09/2006US20060029605 Use of ErbB receptor ligands in treating diabetes
02/09/2006US20060029604 Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform
02/09/2006US20060029603 Immunoglobulins
02/09/2006US20060029602 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner
02/09/2006US20060029598 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
02/09/2006US20060029597 IgA antibody protein as a cytotoxic drug
02/09/2006US20060029596 Administering to the tumor an adenovirus vector, overexpresses an adenovirus death protein; promoting the death of neoplastic cells; telomerase resistance; anticancer biodrugs
02/09/2006US20060029595 Methods of using human receptor protein 4-1BB
02/09/2006US20060029594 Interleukins (IL-5); for treating conditions associated with excess eosinophil production (such as chronic eosinophilic pneumonia, allergic bronchopulmonary aspergillosis, coeliac disease and/or gastroenteritis)
02/09/2006US20060029593 Immunoglobulins having complementarity determining regions, heavy and light chain variable regions from humans that specifically bind to an antigen with affinity, used for in vivo therapy and diagnosis
02/09/2006US20060029584 Methods for improving cell line activity in immunoisolation devices
02/09/2006US20060029583 Method for the genetic activation of cells and uses of said cells
02/09/2006US20060029581 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
02/09/2006US20060029580 Method for treating a condition with neural progenitor cells derived from whole bone marrow
02/09/2006US20060029579 Contacting a lymphocyte population with an effective amount of a peptide mixture comprising a native agonist peptide from a tumor-associated antigen, wherein the agonist peptide comprises a disclosed amino acid sequence and an analog peptide sequence
02/09/2006US20060029575 Compositions and methods for producing and using homogenous neuronal cell transplants
02/09/2006US20060029547 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders
02/09/2006DE19736343B4 Verfahren zur Erhöhung der Genexpression von Saccharose Synthase Method for increasing the gene expression of saccharose synthase
02/09/2006DE102004036079A1 Preparation of cell culture based reaction pattern in vertebrate cell (RiV)-specific medicament, for e.g. treating tumor, HIV-infection, psoriasis and rheumatic diseases, comprises strongly heating RiV-preparation for ten minutes
02/09/2006DE102004034461A1 Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren Gene therapy of solid tumors by retroviral, with arena virus glycoprotein pseudotyped vectors
02/09/2006DE10104721B4 Verfahren zur Erhöhung des Gehalts von Schwefelverbindungen in Pflanzen A method for increasing the content of sulfur compounds in plants
02/09/2006CA2579790A1 Npc1l1 and npc1l1 inhibitors and methods of use thereof
02/09/2006CA2576037A1 Method of producing glycoprotein composition
02/09/2006CA2575614A1 Differentiation of stem cells
02/09/2006CA2575606A1 Hai-1 and hai-2 in cancer therapy
02/09/2006CA2575348A1 Novel anti-igf-ir antibodies and uses thereof
02/09/2006CA2575127A1 Preparation of organisms with faster growth and/or higher yield
02/09/2006CA2574791A1 Compositions and methods of using angiopoietin-like 4 protein
02/09/2006CA2574593A1 Genetically modified host cells and use of same for producing isoprenoid compounds
02/09/2006CA2574496A1 Methods for diagnosis using anti-cytokine receptor antibodies
02/09/2006CA2572113A1 Methods of using regenerative cells to promote wound healing
02/09/2006CA2570643A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof
02/08/2006EP1624065A2 Agarase and gene thereof
02/08/2006EP1624061A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/08/2006EP1624060A2 Control of gene expression
02/08/2006EP1624055A1 Spheroid preparation
02/08/2006EP1624054A1 Cell culture method and cultured tissue
02/08/2006EP1624053A1 Substances for preventing and treating autoimmune diseases
02/08/2006EP1624050A2 Multiply-substituted protease variants
02/08/2006EP1623990A2 Compositions and methods for the treatment of tumours
02/08/2006EP1623989A1 Compositions and methods for the diagnosis of tumours
02/08/2006EP1623222A2 Ranbp2 as modifier of the pten/igf pathway and methods of use
02/08/2006EP1623221A2 Modulators of the p2y10 receptor useful in altering t lymphocyte function
02/08/2006EP1623037A2 Improved method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding genetic tools, as well as the applications of these non-pathogenic amplicons vectors
02/08/2006EP1623034A2 Mechanisms of myoblast transfer in treating heart failure
02/08/2006EP1623031A1 A method of increasing the total or soluble carbohydrate content or sweetness of an endogenous carbohydrate by catalysing the conversion of an endogenous sugar to an alien sugar.
02/08/2006EP1623023A1 Cultures of e1-immortalized cells and processes for culturing the same to increase product yields therefrom
02/08/2006EP1623022A2 Method, apparatus and system for separating eucaryotic or procaryotic cells or other particularly biological material from a suspension
02/08/2006EP1623021A1 Method for storing tumor cells
02/08/2006EP1623020A2 Genomic and proteomic approaches for the development of cell culture medium
02/08/2006EP1623019A1 Restricted glucose feed for animal cell culture
02/08/2006EP1623018A2 Mptens as modifiers of the pten/igf pathway and methods of use
02/08/2006EP1623017A1 Generation and isolation of antigen-specific t cells
02/08/2006EP1623016A2 Polynucleotides encoding novel variants of the trp channel family member, ltrpc3
02/08/2006EP1623011A2 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
02/08/2006EP1623009A2 Transfection kinetics and structural promoters
02/08/2006EP1622941A2 Method of producing an antibody to epidermal growth factor receptor
02/08/2006EP1622935A2 Spex compositions and methods of use
02/08/2006EP1622684A2 Compositions and methods relating to novel compounds and targets thereof
02/08/2006EP1622635A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
02/08/2006EP1622572A2 Conjugates and compositions for cellular delivery
02/08/2006EP1622570A2 Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof
02/08/2006EP1546346A4 Embryonic stem cell markers and uses thereof
02/08/2006EP1503652A4 Vascularization enhanced graft constructs
02/08/2006EP1442126B1 Method for selecting genetically transformed cells
02/08/2006EP1423082A4 Plasma protein matrices and methods for their preparation
02/08/2006EP1352052B1 Method for preparing submicron particle suspensions of pharmaceutical agents
02/08/2006EP1156822B1 Iin vitro method for synchronisation of oocyte maturation
02/08/2006EP1093514B1 Non-macroporous inorganic support for bioremediation
02/08/2006EP1068297B1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
02/08/2006EP1039933B1 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE AND FOR THE PRODUCTION OF $i(IN VITRO) MABS
02/08/2006EP1032680B1 A novel method for the integration of foreign dna into eukaryoticgenomes
02/08/2006EP1025230B1 ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE
02/08/2006EP0969855B1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
02/08/2006EP0812356B1 Prostate-specific membrane antigen and uses thereof
02/08/2006EP0783527B1 Cathepsin o2 protease
02/08/2006EP0765391B1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit
02/08/2006EP0729514B1 Chimeric regulatory regions and gene cassettes for expression of genes in plants
02/08/2006EP0687296B1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals
02/08/2006CN1732267A Method of transferring gene into t cells
02/08/2006CN1732266A Plants having modified growth characteristics and a method for making the same
02/08/2006CN1732262A Methods and means for modulating cellulose biosynthesis in fiber producing plants
02/08/2006CN1732258A High expression locus vector based on ferritin heavy chain gene locus
02/08/2006CN1730663A Oral mucosa epithelial cell canceration model
02/08/2006CN1730656A DNA which code Mycoplasma mycoides subspecies N terminal lipoprotein
02/08/2006CN1730652A Method for preserving and proliferating jujube witches broom pytoplasma in vitro of host
02/08/2006CN1730651A Broomrape callus induction method and induction medium
02/08/2006CN1730117A Peripheral nerve regeneration conduit and process for preparing the same
02/08/2006CN1240837C Modification of plant fibres
02/08/2006CN1240831C Method for producing heterologous secreting protein from Chinese hamster ovary cells grown on microcarriers
02/08/2006CN1240717C Low-toxicity human interferon-alpha analog
02/08/2006CN1240272C In OVO activation of an avian egg in the shell and method for fertilizing avian egg inside shell
02/07/2006US6995305 Hybrid maize plant and seed 33T39
02/07/2006US6995304 Hybrid maize plant & seed 33H05
02/07/2006US6995303 Soybean variety XB34A05
02/07/2006US6995300 Isolation of SU1, a starch debranching enzyme, the product of the maize gene sugary1